Rapid evaluation of the COVID-19 pandemic response in palliative and end of life care: national delivery, workforce and symptom management (CovPall)

快速评估姑息治疗和临终关怀中的 COVID-19 大流行应对措施:全国交付、劳动力和症状管理 (CovPall)

基本信息

  • 批准号:
    MR/V012908/1
  • 负责人:
  • 金额:
    $ 35.8万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2020
  • 资助国家:
    英国
  • 起止时间:
    2020 至 无数据
  • 项目状态:
    已结题

项目摘要

The COVID-19 pandemic is placing an unprecedented strain on health care services. Although many people survive, an estimated 1 to 4% die from this disease. There are more than 10,000 UK deaths from COVID-19, with numbers escalating. Many of the symptoms, such as breathlessness, fever, agitation and pain, are very distressing. But in this new disease these symptoms are not well understood. Palliative care services are adapting rapidly to this situation, but in different ways, not knowing what is best. This research aims to rapidly evaluate the palliative care response in COVID-19 to improve care now and in the future. There are two main components, called work packages (WPs), to the research. WP1 surveys, UK wide, palliative care medical or nursing leads, about their changes in practice, how they deploy the workforce, volunteers and technology, their innovations and challenges. WP2 collects data about patients' symptoms, how they change over time, and the effects of treatments. We collect this information immediately and quickly (phase I), and then repeat the data collection after 6-8 weeks (phase II) to understand how practice is changing. We involve patients, families, the public, policy makers and services in all stages of the research. We release early findings, to help catalyse an effective response.
COVID-19疫情对医疗服务造成前所未有的压力。虽然许多人幸存下来,但估计有1 - 4%的人死于这种疾病。英国有1万多人死于COVID-19,人数还在不断上升。许多症状,如呼吸困难,发烧,激动和疼痛,是非常痛苦的。但在这种新的疾病中,这些症状还没有得到很好的理解。姑息治疗服务正在迅速适应这种情况,但方式不同,不知道什么是最好的。这项研究旨在快速评估COVID-19的姑息治疗反应,以改善现在和未来的护理。有两个主要组成部分,称为工作包(WP)的研究。WP 1调查,英国范围内,姑息治疗医疗或护理领导,关于他们在实践中的变化,他们如何部署劳动力,志愿者和技术,他们的创新和挑战。WP 2收集有关患者症状的数据,它们如何随时间变化以及治疗效果。我们立即快速地收集这些信息(第一阶段),然后在6-8周后重复数据收集(第二阶段),以了解实践如何变化。我们让患者、家庭、公众、政策制定者和服务部门参与研究的各个阶段。我们发布早期调查结果,以帮助促进有效的应对措施。

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Understanding the impact of the Covid-19 pandemic on delivery of rehabilitation in specialist palliative care services: An analysis of the CovPall-Rehab survey data
了解 Covid-19 大流行对专业姑息治疗服务中康复服务的影响:对 CovPall-Rehab 调查数据的分析
  • DOI:
    10.1101/2021.04.13.21255380
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Bayly J
  • 通讯作者:
    Bayly J
Intersectional effects of gender and ethnicity? A quantitative analysis of bonus pay gap data for Shelford Hospital consultants.
性别和种族的交叉影响?
  • DOI:
    10.1136/leader-2021-000507
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    2.7
  • 作者:
    Bajwah S
  • 通讯作者:
    Bajwah S
sj-pdf-2-pmj-10.1177_02692163211063397 - Supplemental material for Understanding the impact of the Covid-19 pandemic on delivery of rehabilitation in specialist palliative care services: An analysis of the CovPall-Rehab survey data
sj-pdf-2-pmj-10.1177_02692163211063397 - 了解 Covid-19 大流行对专业姑息治疗服务中康复的影响的补充材料:对 CovPall-Rehab 调查数据的分析
  • DOI:
    10.25384/sage.17705347
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Bayly J
  • 通讯作者:
    Bayly J
Changing patterns of mortality during the COVID-19 pandemic: population-based modelling to understand palliative care implications
COVID-19 大流行期间死亡率模式的变化:基于人群的模型以了解姑息治疗的影响
  • DOI:
    10.1101/2020.06.07.20124693
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Bone A
  • 通讯作者:
    Bone A
Top Ten Tips Palliative Care Clinicians Should Know About Cachexia
  • DOI:
    10.1089/jpm.2022.0598
  • 发表时间:
    2023-01-31
  • 期刊:
  • 影响因子:
    2.8
  • 作者:
    Blum, David;Vagnildhaug, Ola Magne;Schloegl, Mathias
  • 通讯作者:
    Schloegl, Mathias
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Irene Higginson其他文献

Determinants of Healthcare Costs in the Last Year of Life (TH316-A)
  • DOI:
    10.1016/j.jpainsymman.2012.10.048
  • 发表时间:
    2013-02-01
  • 期刊:
  • 影响因子:
  • 作者:
    E. Iris Groeneveld;Fliss Murtagh;Yvonne Kaloki;Claudia Bausewein;Irene Higginson
  • 通讯作者:
    Irene Higginson
Measuring the Intensity, Cost and Duration of Palliative Care-Relevant Cases Among all Hospitalizations in Three US and UK Hospitals (TH316-B)
  • DOI:
    10.1016/j.jpainsymman.2012.10.049
  • 发表时间:
    2013-02-01
  • 期刊:
  • 影响因子:
  • 作者:
    J Brian Cassel;Kathleen Kerr;Leanne Yanni;Fliss Murtagh;Irene Higginson;Michael Myers;Teresa Day;Ade Adefisan
  • 通讯作者:
    Ade Adefisan
International Measurement of Cost Avoidance Through Specialist Palliative Care: A Universally Applicable Approach (TH316-C)
  • DOI:
    10.1016/j.jpainsymman.2012.10.050
  • 发表时间:
    2013-02-01
  • 期刊:
  • 影响因子:
  • 作者:
    J Brian Cassel;Fliss Murtagh;Irene Higginson;Kathleen Kerr
  • 通讯作者:
    Kathleen Kerr
How Many People Need Palliative Care? A Refined Method to Estimate the Size of a Palliative Care Population Nationally (S745)
  • DOI:
    10.1016/j.jpainsymman.2012.10.162
  • 发表时间:
    2013-02-01
  • 期刊:
  • 影响因子:
  • 作者:
    Fliss Murtagh;Claudia Bausewein;Julia Verne;Yvonne Kaloki;E. Iris Groeneveld;Irene Higginson
  • 通讯作者:
    Irene Higginson
Preferences of Older People With a Life-Limiting Illness: A Discrete Choice Experiment
  • DOI:
    10.1016/j.jpainsymman.2022.04.180
  • 发表时间:
    2022-08-01
  • 期刊:
  • 影响因子:
  • 作者:
    Bridget M Johnston;Barbara Daveson;Charles Normand;Karen Ryan;Melinda Smith;Regina McQuillan;Irene Higginson;Lucy Selman;Katy Tobin; BuildCARE
  • 通讯作者:
    BuildCARE

Irene Higginson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Irene Higginson', 18)}}的其他基金

Methods for evaluating service delivery models for end of life care (EoLC): development of best practice guidance
评估临终关怀 (EoLC) 服务提供模式的方法:制定最佳实践指南
  • 批准号:
    G0802654/1
  • 财政年份:
    2009
  • 资助金额:
    $ 35.8万
  • 项目类别:
    Research Grant

相似国自然基金

基于重要农地保护LESA(Land Evaluation and Site Assessment)体系思想的高标准基本农田建设研究
  • 批准号:
    41340011
  • 批准年份:
    2013
  • 资助金额:
    20.0 万元
  • 项目类别:
    专项基金项目
基于观测角度的汉语名词性隐喻逻辑释义和评价方法研究
  • 批准号:
    61075058
  • 批准年份:
    2010
  • 资助金额:
    25.0 万元
  • 项目类别:
    面上项目
面向认知网络的自律计算模型及评价方法研究
  • 批准号:
    60973027
  • 批准年份:
    2009
  • 资助金额:
    30.0 万元
  • 项目类别:
    面上项目

相似海外基金

CO-CREATE-Ex: Community-engaged Optimization of COVID-19 Rapid Evaluation And TEsting Experiences
CO-CREATE-Ex:社区参与优化 COVID-19 快速评估和测试体验
  • 批准号:
    10617124
  • 财政年份:
    2022
  • 资助金额:
    $ 35.8万
  • 项目类别:
Development of a rapid multiplex CRISPR-based testing pathway for tuberculosis and COVID-19
开发基于 CRISPR 的结核病和 COVID-19 快速多重检测途径
  • 批准号:
    10621379
  • 财政年份:
    2022
  • 资助金额:
    $ 35.8万
  • 项目类别:
CO-CREATE-Ex: Community-engaged Optimization of COVID-19 Rapid Evaluation And TEsting Experiences
CO-CREATE-Ex:社区参与优化 COVID-19 快速评估和测试体验
  • 批准号:
    10845417
  • 财政年份:
    2022
  • 资助金额:
    $ 35.8万
  • 项目类别:
Development of a rapid multiplex CRISPR-based testing pathway for tuberculosis and COVID-19
开发基于 CRISPR 的结核病和 COVID-19 快速多重检测途径
  • 批准号:
    10432930
  • 财政年份:
    2022
  • 资助金额:
    $ 35.8万
  • 项目类别:
Faithful Response II: COVID-19 Rapid Test-to-Treat with African American Churches
忠实响应 II:与非裔美国教会一起进行 COVID-19 快速检测治疗
  • 批准号:
    10845416
  • 财政年份:
    2022
  • 资助金额:
    $ 35.8万
  • 项目类别:
Faithful Response II: COVID-19 Rapid Test-to-Treat with African American Churches
忠实响应 II:与非裔美国教会一起进行 COVID-19 快速检测治疗
  • 批准号:
    10617112
  • 财政年份:
    2022
  • 资助金额:
    $ 35.8万
  • 项目类别:
AGILE: Seamless Phase I/IIa Platform for the Rapid Evaluation of Candidates for COVID-19 treatment
AGILE:用于快速评估 COVID-19 治疗候选者的无缝 I/IIa 期平台
  • 批准号:
    MR/V028391/1
  • 财政年份:
    2021
  • 资助金额:
    $ 35.8万
  • 项目类别:
    Research Grant
Evaluation of Operation Safer Ground: A Community-Level Rapid Housing Intervention for People Vulnerable to COVID-19.
Safer Ground 行动评估:针对 COVID-19 易感人群的社区级快速住房干预措施。
  • 批准号:
    10471439
  • 财政年份:
    2021
  • 资助金额:
    $ 35.8万
  • 项目类别:
Rapid Structure-Function MRI of the Lung for Post-COVID-19 Management
用于 COVID-19 后管理的肺部快速结构功能 MRI
  • 批准号:
    10181576
  • 财政年份:
    2021
  • 资助金额:
    $ 35.8万
  • 项目类别:
Evaluation of Operation Safer Ground: A Community-Level Rapid Housing Intervention for People Vulnerable to COVID-19.
Safer Ground 行动评估:针对 COVID-19 易感人群的社区级快速住房干预措施。
  • 批准号:
    10619003
  • 财政年份:
    2021
  • 资助金额:
    $ 35.8万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了